The impact of tofacitinib on quality of life in patients with moderate-to-severe psoriasis- An observational study

Conclusion: Tofacitinib demonstrated a significant improvement in psoriasis disease severity and symptoms with 12 weeks' therapy.

Source: Indian Journal of Dermatology - June 30, 2023 Category: Dermatology Authors: Alpana Mohta Asha Nyati Bhikam Chand Ghiya Rajesh Dutt Mehta Suresh Kumar Jain Source Type: research